Document is current
Any future updates will be listed below
-
Authors
Wen, Heling
Zhang, Rui
Zhou, Zhenke
Hong, Min
Huang, Zheng
Jiang, Yifeng
Chen, Yu
Peng, Lei
-
Funding
Funding for this research was provided by:
the Foundation of Science and Technology Department of Sichuan Province (No. 2023NSFSC0590)
The Medico-Engineering Cooperation Funds from University of Electronic Science and Technology of China (No.ZYGX2021YGLH223)
Chengdu Science and Technology Bureau (2022-YF05-01940-SN)
Sichuan Science and Technology Program (2024NSFSC0688)
"PRO•Run" Fund of the Nephrology Group of CEBM (KYJ202206-0003-1)
- License Information
-
More Information
Article History
Received: 22 June 2024
Accepted: 23 September 2024
First Online: 29 September 2024
Declarations
:
: The Institutional Review Board and Ethics Committee of The Affiliated Tumor Hospital of Chengdu Medical College approved the study protocols and written informed participants’ consent (Ref: 2021 − 117). Before enrolment, informed consent was obtained from all the participants and/or legal guardians for the study, wherein they were informed that they could freely withdraw from the study. There would be no negative consequences from opting not to participate in the study. All methods were carried out in accordance with relevant guidelines and regulations, including the Chinese Prevention of Cruelty to Human Subjects Act and the Code of Practice for the Care and Use of Human Subjects for Scientific Purposes.
: Not applicable.
: The authors declare no competing interests.
